Honeywell International’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-448,100
Closed -$38.3M 171
2017
Q3
$38.3M Buy
448,100
+218,100
+95% +$17.9M 1.35% 18
2017
Q2
$18.9M Sell
230,000
-123,000
-35% -$10M 0.71% 56
2017
Q1
$29.7M Buy
353,000
+125,000
+55% +$10M 0.96% 31
2016
Q4
$16.8M Buy
228,000
+85,000
+59% +$6.33M 0.56% 69
2016
Q3
$11.5M Buy
143,000
+18,000
+14% +$1.44M 0.4% 95
2016
Q2
$9.84M Buy
+125,000
New +$9.41M 0.25% 119
2014
Q2
Sell
-230,000
Closed -$13.5M 181
2014
Q1
$13.5M Sell
230,000
-370,000
-62% -$20.6M 0.33% 128
2013
Q4
$30.6M Buy
600,000
+450,000
+300% +$22.5M 0.73% 42
2013
Q3
$7.55M Buy
+150,000
New +$7.85M 0.19% 125

Other funds holding LLY

Honeywell International's LLY Position: Q4 2017 in Review

Honeywell International sold out of Eli Lilly (LLY) in Q4 2017, closing a stake of 448,100 shares — an estimated $38.3M sold.

Honeywell International first reported a position in LLY in Q3 2013 and held it in 9 quarters. The position peaked at $38.3M in Q3 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • Honeywell International reported no remaining Eli Lilly position as of Q4 2017 after selling out during the quarter.
  • Honeywell International sold 448,100 Eli Lilly shares in Q4 2017, an estimated $38.3M.
  • Honeywell International first reported a position in Eli Lilly in Q3 2013 and held it in 9 quarters.
  • Honeywell International's Eli Lilly position peaked at $38.3M in Q3 2017.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on Honeywell International's 13F filing for Q4 2017, filed 9 Feb 2018.